S
SBFM
Sunshine Biopharma Inc
1.140
+0.030+2.70%After Hours: 1.111 -0.029 -2.51%19:34 09/04 EDT
OPEN/PREV CLOSE1.180/1.140
TODAY RANGE1.135-1.235
VOL288.18K
MARKET CAP4.46M
52 WEEK RANGE1.010-24.30
AVG VOL (3M)532.10K
% TURNOVER7.42%
TURNOVER--
P/E (TTM)-0.1146
% RANGE8.77%
EPS(TTM)-10.0329
P/E(FORWARD)-0.5897
P/B0.0997
BVPS11.53
DIVIDEND--
P/S0.0155
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.38M
SHARES OUTSTANDING3.88M
NEXT EARNINGS11/11-11/16
FREE FLOAT3.81M
LOT SIZE1
EX-DATE06/01/2026
News
Press Releases
Financial Reports
Profile
TipRanks·08/31 13:25
Sunshine Biopharma announces Health Canada approval for atenolol
TipRanks·08/28 20:58
Sunshine Biopharma Announces Upcoming Board Leadership Change
TipRanks·08/28 20:20
Sunshine Biopharma files to sell 24.48M shares of common stock
TipRanks·08/26 13:35
Sunshine Biopharma provides update, outlines plans for oncology project
Benzinga·08/26 12:31
EXCLUSIVE: Sunshine Biopharma Advances Vaccine Strategy for Lung Cancer
Benzinga·08/19 12:30
EXCLUSIVE: Sunshine Biopharma Secures Canadian Approval for Generic Hypertension Drug
TipRanks·08/07 13:06
Sunshine Biopharma launches generic amoxicillin formulation in Canada
TipRanks·08/04 13:16
Sunshine announces approval of generic Dienogest tablets for Canadian market
Benzinga·08/04 12:31
EXCLUSIVE: Sunshine Biopharma Targets Canadian Market with New Women's Health Drug Approval
TipRanks·08/03 13:19
Sunshine Biopharma Adjusts Series B Warrant Terms
TipRanks·07/28 12:21
Sunshine Biopharma announces approval of generic Ondansetron tablets
Benzinga·07/20 21:05
12 Health Care Stocks Moving In Monday's After-Market Session
Same Industry
Name/Symbol
Change%
Price